| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial
|
Johnston, Stephen R D
|
|
|
24 |
1 |
p. 77-90
|
artikel
|
| 2 |
Brain cancer after radiation exposure from CT examinations of children and young adults: results from the EPI-CT cohort study
|
Hauptmann, Michael
|
|
|
24 |
1 |
p. 45-53
|
artikel
|
| 3 |
Bridging the gender gap in childhood cancer: a call to action
|
Prasad, Maya
|
|
|
24 |
1 |
p. 3-4
|
artikel
|
| 4 |
Cancer research in Europe: a focus on children and young people
|
Vassal, Gilles
|
|
|
24 |
1 |
p. 8-9
|
artikel
|
| 5 |
Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries
|
Soerjomataram, Isabelle
|
|
|
24 |
1 |
p. 22-32
|
artikel
|
| 6 |
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial
|
Mina, Roberto
|
|
|
24 |
1 |
p. 64-76
|
artikel
|
| 7 |
Chest mass in a transgender man after top surgery
|
Cortina, Chandler S
|
|
|
24 |
1 |
p. e57
|
artikel
|
| 8 |
Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma – Authors' reply
|
Powles, Thomas
|
|
|
24 |
1 |
p. e1-e2
|
artikel
|
| 9 |
Correction to Lancet Oncol 2022; 23: 1133–44
|
|
|
|
24 |
1 |
p. e10
|
artikel
|
| 10 |
Correction to Lancet Oncol 2023; 24: 91–106
|
|
|
|
24 |
1 |
p. e10
|
artikel
|
| 11 |
Correction to Lancet Oncol 2023; 24: e11–56
|
|
|
|
24 |
1 |
p. e10
|
artikel
|
| 12 |
Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma
|
Mo, Dun-Chang
|
|
|
24 |
1 |
p. e7
|
artikel
|
| 13 |
Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma – Authors' reply
|
Long, Georgina V
|
|
|
24 |
1 |
p. e8
|
artikel
|
| 14 |
Dobbs v Jackson and fertility preservation among adolescents and young adults with cancer
|
Au, Lauren
|
|
|
24 |
1 |
p. e5
|
artikel
|
| 15 |
Drug supply issues affecting cancer care in Latin America
|
Das, Manjulika
|
|
|
24 |
1 |
p. 12
|
artikel
|
| 16 |
Effective treatment based on monitoring bESR1 mutations
|
Hirai, Hoshie
|
|
|
24 |
1 |
p. e3
|
artikel
|
| 17 |
Effective treatment based on monitoring bESR1 mutations – Authors' reply
|
Bidard, Francois-Clément
|
|
|
24 |
1 |
p. e4
|
artikel
|
| 18 |
Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study
|
Lee, Colin Y C
|
|
|
24 |
1 |
p. 107-116
|
artikel
|
| 19 |
England on track to eliminate hepatitis C
|
Burki, Talha Khan
|
|
|
24 |
1 |
p. 16
|
artikel
|
| 20 |
European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission
|
Lawler, Mark
|
|
|
24 |
1 |
p. e11-e56
|
artikel
|
| 21 |
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes
|
Garcia-Pelaez, José
|
|
|
24 |
1 |
p. 91-106
|
artikel
|
| 22 |
GPs to get direct access to cancer diagnostic tests
|
Wilkinson, Emma
|
|
|
24 |
1 |
p. 13
|
artikel
|
| 23 |
Groundshot: a pan-European, patient-centred, and data-driven approach to tackling cancer
|
Costa, Márcia
|
|
|
24 |
1 |
p. 5-6
|
artikel
|
| 24 |
Help Us Help You campaign is no help at all
|
The Lancet Oncology,
|
|
|
24 |
1 |
p. 1
|
artikel
|
| 25 |
ICGC-ARGO precision medicine: an update on targeted therapy based on longitudinal analysis of tumour heterogeneity and evolution in colorectal cancer
|
Kotani, Daisuke
|
|
|
24 |
1 |
p. 20-21
|
artikel
|
| 26 |
Inequalities in cancer prevention and care across Europe
|
Berchet, Caroline
|
|
|
24 |
1 |
p. 10-11
|
artikel
|
| 27 |
Innovative alternatives for metastatic CRPC after enzalutamide
|
Medina, Camilo A
|
|
|
24 |
1 |
p. e9
|
artikel
|
| 28 |
Kenji López-Cuevas–Cáncer Warriors de México Foundation
|
Gourd, Elizabeth
|
|
|
24 |
1 |
p. 19-20
|
artikel
|
| 29 |
New evidence for brain cancer risk after a single paediatric CT scan
|
Hamada, Nobuyuki
|
|
|
24 |
1 |
p. 2-3
|
artikel
|
| 30 |
New perspectives on the body
|
Stirrups, Robert
|
|
|
24 |
1 |
p. 18-19
|
artikel
|
| 31 |
Organisations welcome first smoke-free prison in Western Australia
|
Das, Manjulika
|
|
|
24 |
1 |
p. 15
|
artikel
|
| 32 |
Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAF V600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study
|
Ascierto, Paolo A
|
|
|
24 |
1 |
p. 33-44
|
artikel
|
| 33 |
Sex disparity in childhood cancer in India: a multi-centre, individual patient data analysis
|
Bhatia, Kanu Priya
|
|
|
24 |
1 |
p. 54-63
|
artikel
|
| 34 |
The impact of GDPR on data sharing for European cancer research
|
Lawlor, Rita T
|
|
|
24 |
1 |
p. 6-8
|
artikel
|
| 35 |
The people behind the numbers: women with breast cancer
|
Montel, Lisa
|
|
|
24 |
1 |
p. 17-18
|
artikel
|
| 36 |
Tobacco and e-cigarette use remains high among young people in the USA
|
Nelson, Roxanne
|
|
|
24 |
1 |
p. 14
|
artikel
|
| 37 |
Treatment-related thoracic soft tissue sarcomas in survivors of breast cancer
|
Hu, Xianglin
|
|
|
24 |
1 |
p. e6
|
artikel
|
Tijdschrift beschrijving